Key result
Community pharmacy follow-up and education significantly lowers cardiovascular risk scores versus usual care.
Why the study?
The study was conducted to determine the influence of a complex intervention based on pharmacotherapeutic follow-up and therapeutic education protocols on clinical and educational parameters of patients at cardiovascular risk attending community pharmacies.
Does a complex intervention based on pharmacotherapeutic follow-up and therapeutic education improve clinical and educational parameters in elderly patients at cardiovascular risk?
RCT (n=85)
Unblinded
Randomized by an external person
Yes
Does a complex intervention based on pharmacotherapeutic follow-up and therapeutic education improve clinical and educational parameters in elderly patients at cardiovascular risk?
A pharmacist-led intervention combining pharmacotherapeutic follow-up and therapeutic education significantly improves cardiovascular risk profiles, blood pressure, and health literacy in elderly patients.
Answers are grounded in this paper and cite their sources.
Supports pharmacist-led follow-up and education in community pharmacies for elderly CV risk patients; extends evidence for non-physician interventions in primary prevention.
The aim was to determine the influence of a complex intervention based on pharmacotherapeutic follow-up (PTF) and the application of therapeutic education (TE) protocols on the clinical and educational parameters of patients at cardiovascular risk (CVR) attending community pharmacies (CPs). A prospective, longitudinal, randomized, controlled clinical trial was conducted over 6 months in patients from four Spanish CPs, divided into control (CG) and intervention (IG) groups. CG patients received usual pharmacy care and IG patients received a PTF- and TE-based intervention. The sample consisted of 85 elderly patients. After pharmaceutical follow-up of the IG patients, the following results were observed: significant reductions in cardiovascular risk (CVR) (p < 0.005), blood pressure (BP) (p < 0.05), and sedentary lifestyle (p < 0.001), as well as an improved knowledge of CVR and cardiovascular risk factors (CVRFs) (p < 0.001). Target values for BP were achieved in 27.2% of patients and for triglycerides in 12.4% of patients. The PTF of the patients showed that 29.2% did not have the expected response to some treatments, while 25% had untreated pathologies and 10% had adverse reactions. The TE protocols related to the patients’ educational needs, applied individually and in conjunction with the PTF, were able to improve their lifestyle habits, their knowledge of CVR, CVRFs, and pharmacotherapy, and their clinical parameters, and, thus, the level of development of their disease
No takes yet. Share an insight, caveat, or question.
Jurado et al. (2025) conducted an RCT in Cardiovascular risk (n=85). Pharmacotherapeutic follow-up and therapeutic education vs. Usual pharmacy care was evaluated on Change in cardiovascular risk (CVR) score (p=0.003). A complex intervention combining pharmacotherapeutic follow-up and therapeutic education in community pharmacies significantly reduced cardiovascular risk scores (p=0.003) compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: